Package 33342-096-07

{"route": ["ORAL"], "spl_id": "9826ed5e-829c-4e94-9c60-761acb892d74", "openfda": {"upc": ["0333342096074"], "unii": ["OTT9J7900I"], "rxcui": ["349251"], "spl_set_id": ["532755cb-1cd3-4774-97af-05a53779b65f"], "manufacturer_name": ["Macleods Pharmaceuticals Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 TABLET, FILM COATED in 1 BOTTLE (33342-096-07)", "package_ndc": "33342-096-07", "marketing_start_date": "20180126"}], "brand_name": "tenofovir disoproxil fumarate", "product_id": "33342-096_9826ed5e-829c-4e94-9c60-761acb892d74", "dosage_form": "TABLET, FILM COATED", "pharm_class": ["Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]", "Nucleoside Reverse Transcriptase Inhibitors [MoA]", "Nucleosides [CS]"], "product_ndc": "33342-096", "generic_name": "tenofovir disoproxil fumarate", "labeler_name": "Macleods Pharmaceuticals Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "tenofovir disoproxil fumarate", "active_ingredients": [{"name": "TENOFOVIR DISOPROXIL FUMARATE", "strength": "300 mg/1"}], "application_number": "ANDA203232", "marketing_category": "ANDA", "marketing_start_date": "20180126", "listing_expiration_date": "20261231"}